Gene · 2182
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acyl-CoA Synthetase Long-Chain Family Member 4 in Liver Injury: Multidimensional Regulation and Therapeutic Potential. | Gastroenterology Res | 2026 | 41822181 | PubTator, text mining | PubMed |
| Vitamin C inhibits ACSL4 to alleviate ferro-aging in primates. | Cell Metab | 2026 | 41819088 | PubTator, text mining | PubMed |
| CXCL12 Promotes Peripheral Nerve Injury Repair by Inhibiting the Ferroptosis-Inflammation Axis via the ERK/Nrf2 Pathway. | Inflammation | 2026 | 41817838 | PubTator, text mining | PubMed |
| Bioinformatics identification of adenosylhomocysteinase (AHCY) as a regulator of ferroptosis in nasopharyngeal carcinoma cells via the Hippo-Yes-associated protein (Hippo-YAP) pathway. | Transl Cancer Res | 2026 | 41815160 | PubTator, text mining | PubMed |
| Scutellarein Attenuates Intervertebral Disc Degeneration by Promoting PINK1/Parkin-Mediated Mitophagy to Alleviate Inflammation, Ferroptosis, and Mitochondrial Dysfunction in Nucleus Pulposus Cells. | Phytother Res | 2026 | 41815012 | PubTator, text mining | PubMed |
| [Mechanism of artesunate-induced ferroptosis in triple-negative breast cancer cells through Wnt/β-catenin signaling pathway]. | Zhongguo Zhong Yao Za Zhi | 2026 | 41814826 | PubTator, text mining | PubMed |
| [Transcriptomics and cell experiments reveal regulatory effect of jatrorrhizine on SAT1-mediated ferroptosis in colorectal cancer cell]. | Zhongguo Zhong Yao Za Zhi | 2026 | 41814763 | PubTator, text mining | PubMed |
| Self-disassembling diatomic nanocluster bomb unlock reciprocal synergistic multi-pathway cancer therapy. | J Nanobiotechnology | 2026 | 41814299 | PubTator, text mining | PubMed |
| NRF2-TERT-ACSL4 pathway inhibits ferroptosis and regulates cytoskeletal dynamics to mitigate ovarian aging. | Int J Biol Macromol | 2026 | 41812952 | PubTator, text mining | PubMed |
| Identifying sorafenib benefit among patients with hepatocellular carcinoma: A transcriptomic and genomic approach. | JHEP Rep | 2026 | 41810428 | PubTator, text mining | PubMed |
| Targeting the NSUN2-DHODH axis reverses ferroptosis resistance and oxaliplatin resistance in colorectal cancer. | Front Pharmacol | 2026 | 41808866 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. | Mol Biomed | 2026 | 41806079 | PubTator, text mining | PubMed |
| AKAP7 is a prognostic biomarker involved in immune infiltration of bladder urothelial carcinoma and correlated with ferroptosis. | Discov Oncol | 2026 | 41806078 | PubTator, text mining | PubMed |
| Umbilical cord mesenchymal stem cells and their extracellular vesicles attenuate cryopreservation-induced ovarian injury via the suppression of ferroptosis in an in vitro culture system. | Mater Today Bio | 2026 | 41800454 | PubTator, text mining | PubMed |
| Ferroptosis in Parkinson's disease: a review of molecular mechanisms and emerging therapeutic strategies. | Front Neurosci | 2026 | 41799880 | PubTator, text mining | PubMed |
| Phosphatases in tumor cell immune escape: a perspective based on the camouflage, coercion, cytoprotection. | Front Cell Dev Biol | 2026 | 41799437 | PubTator, text mining | PubMed |
| IFI44 Promotes Clear Cell Renal Cell Carcinoma Progression via PRDX1 and Predicts Poor Prognosis. | Research (Wash D C) | 2026 | 41799288 | PubTator, text mining | PubMed |
| Ferroptosis as a therapeutic nexus: traditional Chinese medicine interventions in rheumatoid arthritis. | Front Immunol | 2026 | 41798941 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications. | Front Immunol | 2026 | 41798919 | PubTator, text mining | PubMed |
| The role of ferroptosis in osteoporosis: a cellular perspective on osteoblast, osteoclast and osteocyte dysfunction. | Front Endocrinol (Lausanne) | 2026 | 41798188 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2182/papers?page=16